Literature DB >> 32189070

Warthin's tumour seems to be the most common benign neoplasm of the parotid gland in Germany.

Georgios Psychogios1,2, Ioannis Vlastos3, Rubens Thölken4, Johannes Zenk4.   

Abstract

PURPOSE: Recent reports indicate an increase in the prevalence of Warthin's tumours (adenolymphoma) with percentages which exceed that of pleomorphic adenomas (PA) in the same registries. The purpose of this study is to analyse a large cohort of benign parotid tumours in relation to various demographic and other patients' characteristics that might affect their incidence.
METHODS: A retrospective review of prospective collected data was performed on all patients who have been operated for a parotid mass in the last 5 years. A total of 474 patients with benign lesion were included in the study. Age, gender, smoking status, histological diagnosis, site of lesion, and size of tumour were recorded.
RESULTS: Warthin's tumours were the most common benign lesions, found in 201 (42.4%) parotic glands followed by pleomorphic adenomas found in 138 (29.1%) of these surgical cases. Patients with WT had a mean age of 61.6 years instead of 52 years for PA patients (t = 6.589, p < 0.001). The vast majority (93%) of patients with WT had a current or previous history of smoking compared with 47% of PA patients (p = 0.001). There was a male predominance regarding WT with a male:female (M:F) ratio of 2.3:1, whereas the corresponding ratio of PA was 1:1.4.
CONCLUSIONS: This study confirms the increased regional prevalence of WT reported in studies mainly carried out in central Europe. This could affect future management of WT, which remains largely controversial due to the extremely low malignant potential reported, concurrently with its higher rates of multiplicity and recurrence, as well as the moderately accurate results of FNA biopsies.

Entities:  

Keywords:  Adenolymphoma; Parotid surgery; Pleomorphic adenoma; Prevalence; Warthin’s tumour

Mesh:

Year:  2020        PMID: 32189070     DOI: 10.1007/s00405-020-05894-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

1.  Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations.

Authors:  Orlando Guntinas-Lichius; J Peter Klussmann; Claus Wittekindt; Eberhard Stennert
Journal:  Laryngoscope       Date:  2006-04       Impact factor: 3.325

2.  Evolution and changing trends in surgery for benign parotid tumors.

Authors:  Konstantinos Mantsopoulos; Michael Koch; Nils Klintworth; Johannes Zenk; Heinrich Iro
Journal:  Laryngoscope       Date:  2014-07-14       Impact factor: 3.325

3.  Contemporary diagnosis and management of Warthin's tumor.

Authors:  Robert L Witt; Mary Iacocca; Fady Gerges
Journal:  Del Med J       Date:  2015-01

4.  Outcome, general, and symptom-specific quality of life after various types of parotid resection.

Authors:  Raphael Richard Ciuman; Wolfgang Oels; Rolf Jaussi; Philipp Dost
Journal:  Laryngoscope       Date:  2012-05-01       Impact factor: 3.325

5.  Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population.

Authors:  Z Tian; L Li; L Wang; Y Hu; J Li
Journal:  Int J Oral Maxillofac Surg       Date:  2009-11-29       Impact factor: 2.789

6.  [Salivary gland tumors in the County of Funen, 1984-2003].

Authors:  Kristian Slott Mortensen; Janni Hjortlund; Kristine Bjørndal; Annelise Krogdal; Christian Godballe
Journal:  Ugeskr Laeger       Date:  2008-02-11

7.  The incidence of Warthin tumours and pleomorphic adenomas in the parotid gland over a 25-year period.

Authors:  J C Luers; O Guntinas-Lichius; J P Klussmann; C Küsgen; D Beutner; M Grosheva
Journal:  Clin Otolaryngol       Date:  2016-07-18       Impact factor: 2.597

8.  Salivary gland tumors: a single institution experience in India.

Authors:  Krishnaraj Subhashraj
Journal:  Br J Oral Maxillofac Surg       Date:  2008-07-11       Impact factor: 1.651

Review 9.  Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital.

Authors:  G H Yoo; D W Eisele; F B Askin; J S Driben; M E Johns
Journal:  Laryngoscope       Date:  1994-07       Impact factor: 3.325

10.  Incidence of salivary gland neoplasms in a defined UK population.

Authors:  Patrick J Bradley; Mark McGurk
Journal:  Br J Oral Maxillofac Surg       Date:  2012-10-24       Impact factor: 1.651

View more
  4 in total

Review 1.  Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland.

Authors:  Miquel Quer; Juan C Hernandez-Prera; Carl E Silver; Maria Casasayas; Ricard Simo; Vincent Vander Poorten; Orlando Guntinas-Lichius; Patrick J Bradley; Wai Tong-Ng; Juan P Rodrigo; Antti A Mäkitie; Alessandra Rinaldo; Luiz P Kowalski; Alvaro Sanabria; Remco de Bree; Robert P Takes; Fernando López; Kerry D Olsen; Ashok R Shaha; Alfio Ferlito
Journal:  Diagnostics (Basel)       Date:  2021-08-13

2.  Metastases of Cutaneous Squamous Cell Carcinoma Seem to be the Most Frequent Malignancies in the Parotid Gland: A Hospital-Based Study From a Salivary Gland Center.

Authors:  M Mayer; R Thoelken; M Jering; B Märkl; J Zenk
Journal:  Head Neck Pathol       Date:  2021-02-05

3.  Prospective Assessment of Intraoperative Facial Nerve Monitoring in Patients Undergoing Partial Parotidectomy.

Authors:  Maciej Zieliński; Paweł Sowa; Monika Adamczyk-Sowa; Michał Szlęzak; Maciej Misiołek
Journal:  Biomed Res Int       Date:  2022-03-22       Impact factor: 3.411

Review 4.  Cytologic diagnosis of parotid gland Warthin tumor: Systematic review and meta-analysis.

Authors:  Roie Fisher; Ohad Ronen
Journal:  Head Neck       Date:  2022-05-18       Impact factor: 3.821

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.